Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Decitabine Improves Response Rate and Prolongs Progression Free Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia with Monosomal Karyotype: A Subgroup Analysis of the Daco-16 Trial

Agnieszka Wierzbowska, MD PhD, Ewa Wawrzyniak, PhD, Agnieszka Pluta, MD PhD, Tadeusz Robak, MD PhD, Grzegorz J. Mazur, MD PhD, Anna Dmoszynska, MD PhD, Jaroslav Cermak, MD PhD, Albert Oriol, MD, Farhad Ravandi, MD, Hagop M. Kantarjian, MD

Blood (2015) 126 (23): 1336.

https://doi.org/10.1182/blood.V126.23.1336.1336

Published: 2015

Journal Articles

Improved Outcome of Adult Acute Lymphoblastic Leukemia Treated with Individualized Protocol Adjusted to the Status of Minimal Residual Disease and Age. Interim Analysis of PALG ALL 5–2007 Study

Blood (2010) 116 (21): 2138.

https://doi.org/10.1182/blood.V116.21.2138.2138

Published: 2010

Journal Articles

The Frequency of T Regulatory Cells Modulates the Survival of Multiple Myeloma Patients: Detailed Characterization of Immune Status In Multiple Myeloma

Krzysztof Giannopoulos, Wioletta Kaminska, Anna Dmoszynska, MD, PhD

Blood (2010) 116 (21): 984.

https://doi.org/10.1182/blood.V116.21.984.984

Published: 2010

Journal Articles

Assessment of Minimal Residual Disease (MRD) In Relapsed CLL Patients Treated with Fludarabine and Cyclophosphamide with or without Rituximab (REACH)

Blood (2010) 116 (21): 1390.

https://doi.org/10.1182/blood.V116.21.1390.1390

Published: 2010

Journal Articles

The Outgrowth of CLL Nurselike Cells in Vitro , and Its Relation to Clinical and Hematological Parameters.

Agata A Filip, DVM, PhD, Dorota Koczkodaj, PhD, Tomasz Kubiatowski, MD, PhD, Ewa Wasik-Szczepanek, MD, PhD, Anna Dmoszynska, MD, PhD

Blood (2009) 114 (22): 2360.

https://doi.org/10.1182/blood.V114.22.2360.2360

Published: 2009

Journal Articles

JAK2 Mutational Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients

Bozena Sokolowska, MD, PhD, Aleksandra Nowaczynska, PhD, Ksenia Bykowska, PhD, Sylwia Chocholowska, PhD, Katarzyna Wejksza, PhD, Adam Walter-Cronack, MD, PhD, Martyna Kandefer-Szerszen, PhD, Tomasz Gromek, MD, PhD, M. Anna Kowalska, PhD, Anna Dmoszynska, MD, PhD

Blood (2008) 112 (11): 4542.

https://doi.org/10.1182/blood.V112.11.4542.4542

Published: 2008

Journal Articles

Peptide Vaccination Induces Dynamic Changes in CD4+ and CD8+ T Cell Subsets: Report on the First Peptide Vaccination Trial in Patients with Chronic Lymphocytic Leukemia (CLL)

Krzysztof Giannopoulos, MD, PhD, Malgorzata Kowal, Anna Dmoszynska, MD, PhD, Jacek Rolinski, Kamila Mazurek, Jochen Greiner, Markus Rojewski, Stephan Stilgenbauer, Hartmut Döhner, Michael Schmitt

Blood (2008) 112 (11): 3159.

https://doi.org/10.1182/blood.V112.11.3159.3159

Published: 2008

Journal Articles

The Receptor for Hyaluronic Acid Mediated Motility (RHAMM): Characterization as an Immunotherapeutical Target in Chronic Lymphocytic Leukemia (CLL) and First Results of RHAMM-Derived Peptide Vaccination Trial.

Krzysztof Giannopoulos, MD, PhD, Andreas Buhler, MD, PhD, Jinfei Chen, MD, PhD, Alexander Krober, MD, PhD, Malgorzata Kowal, MD, PhD, Anna Dmoszynska, MD, PhD, Jacek Rolinski, MD, PhD, Jochen Greiner, MD, PhD, Hartmut Dohner, MD, PhD, Stephan Stilgenbauer, MD, PhD, Michael Schmitt, MD, PhD

Blood (2007) 110 (11): 2051.

https://doi.org/10.1182/blood.V110.11.2051.2051

Published: 2007

Journal Articles

Vaccination of B-CLL Patients with Autologous Dendritic Cells Results in Immunological and Clinical Responses.

Iwona Hus, MD, PhD, Michael Schmitt, MD, PhD, Jacek Tabarkiewicz, MD, PhD, Sebastian Radej, MD, Agnieszka Bojarska-Junak, PhD, Kamila Wojas, PhD, Anita Schmitt, MD, PhD, Krzysztof Giannopoulos, MD, PhD, Anna Dmoszynska, MD, PhD, Jacek Rolinski, MD, PhD

Blood (2007) 110 (11): 2052.

https://doi.org/10.1182/blood.V110.11.2052.2052

Published: 2007

Journal Articles

Thalidomide Alone and in Combination with Fludarabine Exerts Distinct Molecular and Antileukemic Effects in B-Cell Chronic Lymphocytic Leukemia.

Krzysztof Giannopoulos, MD, PhD, Anna Dmoszynska, MD, PhD, Malgorzata Kowal, MD, PhD, Ewa Wasik-Szczepanek, MD, PhD, Paulina Wlasiuk, MA, Agnieszka Bojarska-Junak, PhD, Jacek Rolinski, MD, PhD, Stephan Stilgenbauer, MD, PhD, Lars Bullinger, MD, PhD

Blood (2007) 110 (11): 3124.

https://doi.org/10.1182/blood.V110.11.3124.3124

Published: 2007

Journal Articles

Fibrinolytic Activity in Patients with Essential Thrombocythemia.

Bozena Sokolowska, MD, PhD, Aleksandra Nowaczynska, MSc, Katarzyna Wejksza, MSc, Adam Walter-Croneck, MD, Martyna Kandefer-Szerszen, PhD, Tomasz Gromek, MD, M. Anna Kowalska, PhD, Anna Dmoszynska, MD, PhD

Blood (2007) 110 (11): 3223.

https://doi.org/10.1182/blood.V110.11.3223.3223

Published: 2007

Journal Articles

MabThera (Rituximab) Plus Cyclophosphamide, Vincristine and Prednisone (CVP) Chemotherapy Improves Survival in Previously Untreated Patients with Advanced Follicular Non-Hodgkin’s Lymphoma (NHL).

Robert E. Marcus, MB, Philippe Solal-Celigny, MD, Kevin Imrie, MD, FRCPC, John V. Catalano, MD, Anna Dmoszynska, MD, PHD, João C. Raposo, MD, Fritz C. Offner, MD, PHD, José Gomez-Codina, MD, PHD

Blood (2006) 108 (11): 481.

https://doi.org/10.1182/blood.V108.11.481.481

Published: 2006

Journal Articles

Stimulation of Erythropoiesis by Thalidomide in Multiple Myeloma Patients: Its Influence on FasL, TRAIL and Their Receptors on Erythroblasts and Plasma Cells.

Norbert Grzasko, MD, Marek Hus, MD, PhD, Maria Soroka-Wojtaszko, MD, PhD, Piotr Klimek, MSc, Aneta Goracy, MSc, Anna Dmoszynska, MD, PhD

Blood (2005) 106 (11): 5120.

https://doi.org/10.1182/blood.V106.11.5120.5120

Published: 2005

Journal Articles

Lovastatin as Salvage Immunomodulatory Therapy in Patients with Refractory and Relapsed Multipla Myeloma.

Marek Hus, MD, PhD, Norbert Grzasko, MD, Dariusz Jawniak, MD, PhD, Marta Szostek, PhD, Anna Dmoszynska, MD, PhD

Blood (2005) 106 (11): 1567.

https://doi.org/10.1182/blood.V106.11.1567.1567

Published: 2005

Journal Articles

Study of Lenalidomide Plus Dexamethasone Versus Dexamethasone Alone in Relapsed or Refractory Multiple Myeloma (MM): Results of a Phase 3 Study (MM-010).

Meletios A. Dimopoulos, MD, Andrew Spencer, MBBS, Michael Attal, MD, PRD, Miles Prince, MD, Jean-Luc Harousseau, MD, Anna Dmoszynska, MD, PhD, Zhinuan Yu, PhD, Marta Olesnyckyj, RN, BSN, Jerome Zeldis, MD, Robert Knight, MD

Blood (2005) 106 (11): 6.

https://doi.org/10.1182/blood.V106.11.6.6

Published: 2005

Journal Articles

Lovastatin and Thalidomide Have an Synergic Effect on the Rate of Multiple Myeloma Cell Apoptosis in Short Term Cell Cultures.

Monika Podhorecka, MD, PhD, Piotr Klimek, MSc, Norbert Grzasko, MD, Anna Dmoszynska, MD, PhD

Blood (2005) 106 (11): 5121.

https://doi.org/10.1182/blood.V106.11.5121.5121

Published: 2005

Journal Articles

ZAP-70 Versus CD38 Expression as the Prognostic Factors in B-Cell Chronic Lymphocytic Leukemia.

Iwona Hus, MD, PhD, Agnieszka Bojarska-Junak, MD, PhD, Monika Podhorecka, MD, PhD, Ewa Wasik-Szczepanek, MD, PhD, Malgorzata Sieklucka, MD, Katarzyna Skorzynska, MD, Jacek Rolinski, MD, PhD, Anna Dmoszynska, MD, PhD

Blood (2004) 104 (11): 4780.

https://doi.org/10.1182/blood.V104.11.4780.4780

Published: 2004

Journal Articles

Plasma and Intracellular Concentration of TNF and Its Receptors in Peripheral Blood and Bone Marrow in Different Stages of B-CLL.

Jacek Rolinski, MD, PhD, Agnieszka Bojarska-Junak, MD, PhD, Iwona Hus, MD, PhD, Anna Dmoszynska, MD, PhD

Blood (2004) 104 (11): 4781.

https://doi.org/10.1182/blood.V104.11.4781.4781

Published: 2004

NARROW

Decitabine Improves Response Rate and Prolongs Progression Free Survival in Older Patients with Newly Diagnosed Acute Myeloid Leukemia with Monosomal Karyotype: A Subgroup Analysis of the Daco-16 Trial

Improved Outcome of Adult Acute Lymphoblastic Leukemia Treated with Individualized Protocol Adjusted to the Status of Minimal Residual Disease and Age. Interim Analysis of PALG ALL 5–2007 Study

The Frequency of T Regulatory Cells Modulates the Survival of Multiple Myeloma Patients: Detailed Characterization of Immune Status In Multiple Myeloma

Assessment of Minimal Residual Disease (MRD) In Relapsed CLL Patients Treated with Fludarabine and Cyclophosphamide with or without Rituximab (REACH)

The Outgrowth of CLL Nurselike Cells in Vitro , and Its Relation to Clinical and Hematological Parameters.

JAK2 Mutational Status, Hemostatic Risk Factors and Thrombophilic Factors in Essential Thrombocythemia (ET) Patients

Peptide Vaccination Induces Dynamic Changes in CD4+ and CD8+ T Cell Subsets: Report on the First Peptide Vaccination Trial in Patients with Chronic Lymphocytic Leukemia (CLL)

The Receptor for Hyaluronic Acid Mediated Motility (RHAMM): Characterization as an Immunotherapeutical Target in Chronic Lymphocytic Leukemia (CLL) and First Results of RHAMM-Derived Peptide Vaccination Trial.

Vaccination of B-CLL Patients with Autologous Dendritic Cells Results in Immunological and Clinical Responses.

Thalidomide Alone and in Combination with Fludarabine Exerts Distinct Molecular and Antileukemic Effects in B-Cell Chronic Lymphocytic Leukemia.

Fibrinolytic Activity in Patients with Essential Thrombocythemia.

MabThera (Rituximab) Plus Cyclophosphamide, Vincristine and Prednisone (CVP) Chemotherapy Improves Survival in Previously Untreated Patients with Advanced Follicular Non-Hodgkin’s Lymphoma (NHL).

Stimulation of Erythropoiesis by Thalidomide in Multiple Myeloma Patients: Its Influence on FasL, TRAIL and Their Receptors on Erythroblasts and Plasma Cells.

Lovastatin as Salvage Immunomodulatory Therapy in Patients with Refractory and Relapsed Multipla Myeloma.

Study of Lenalidomide Plus Dexamethasone Versus Dexamethasone Alone in Relapsed or Refractory Multiple Myeloma (MM): Results of a Phase 3 Study (MM-010).

Lovastatin and Thalidomide Have an Synergic Effect on the Rate of Multiple Myeloma Cell Apoptosis in Short Term Cell Cultures.

ZAP-70 Versus CD38 Expression as the Prognostic Factors in B-Cell Chronic Lymphocytic Leukemia.

Plasma and Intracellular Concentration of TNF and Its Receptors in Peripheral Blood and Bone Marrow in Different Stages of B-CLL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only